Ambrisentan Tablets and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Ambrisentan Tablets and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ambrisentan
Brand name: Letairis
Synonyms: Ambrisentan
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ambrisentan Tablets-Insulin glulisine
- Ambrisentan Tablets-Insulin Glulisine (Cartridges and Pens)
- Ambrisentan Tablets-Insulin Glulisine (Vials)
- Ambrisentan Tablets-Insulin glulisine Subcutaneous
- Ambrisentan Tablets-Insulin human inhaled Inhalation
- Ambrisentan Tablets-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Amcinonide
- Insulin glargine, recombinant Subcutaneous-Amcinonide Cream and Ointment
- Insulin glargine, recombinant Subcutaneous-Amcinonide Lotion
- Insulin glargine, recombinant Subcutaneous-Amcinonide Ointment
- Insulin glargine, recombinant Subcutaneous-Amcinonide topical
- Insulin glargine, recombinant Subcutaneous-Amcinonide Topical application